感染性组织扩张器的处理
该回顾性研究纳入2017至2022年接受两阶段假体乳房再造并放置组织扩张器的4498例患者,其中305例(338个扩张器)发生感染并符合纳入标准。感染后1年内再造失败率为54%,保乳再造成功率为46%;假体替换扩张器者成功率最高。作者建议静脉抗生素并低阈值手术干预,本中心做法已从介入放射引流转向确定性手术处理。
要点
- 组织扩张器感染后1年内再造失败率为54%,总体保乳再造成功率为46%。
- 黑种人种族和革兰阴性菌培养与感染后1年内再造失败风险增加相关。
- 以假体替换扩张器的患者感染后成功率最高。
核心结论
- 总体而言,因假体周围感染入院患者中46%获得成功保乳。
- 组织扩张器感染患者应开始静脉抗生素,并根据检查和培养数据以低阈值进行手术干预。
- 尽管介入放射可引导假体周围感染的手术干预,本中心的实践已从介入放射引流转向确定性手术处理。
研究设计与样本
- 回顾性综述2017年至2022年接受两阶段假体乳房再造并放置组织扩张器的患者。
- 纳入因组织扩张器感染接受入院静脉抗生素、介入放射引流和/或手术处理的患者。
- 共4498例患者接受假体乳房再造,其中305例(338个组织扩张器)符合纳入标准。
- 再造成功定义为组织扩张器放置后1年维持乳房再造。
主要发现
- Cox模型显示较高的体重指数、高血压、放射治疗、双侧组织扩张器、脱细胞真皮基质使用、乳房切除标本重量增加和保留乳头乳房切除术与组织扩张器感染风险增加相关。
- 组织扩张器感染患者1年内再造失败率为54%。
- Cox模型显示黑种人种族和革兰阴性菌培养与1年内再造失败风险增加相关。
- 以假体替换组织扩张器的患者感染后成功率最高。
临床怎么用
- 作者建议组织扩张器感染患者开始静脉抗生素,并根据检查和培养数据以低阈值进行手术干预。
- 作者指出尽管介入放射可引导假体周围感染的手术干预,本中心的实践已从介入放射引流转向确定性手术处理。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Tissue expander (TE) infection is a critical postoperative complication in 2-stage implant-based breast reconstruction (IBBR). The authors assessed risk factors associated with TE infection and reconstructive loss and examined reconstructive salvage rates. METHODS: The authors retrospectively reviewed patients who underwent IBBR with TE placement from 2017 to 2022. Included were patients with TE infection treated with admission and intravenous antibiotics, interventional radiology (IR) drainage, and/or operative management (washout with or without TE removal and TE replacement, TE removal and replacement with implant, and/or TE removal without replacement). Reconstructive success was defined as maintenance of breast reconstruction for 1 year after TE placement. RESULTS: Of 4498 patients who underwent IBBR, 305 (338 TEs) met the inclusion criteria. Cox modeling showed that higher body mass index, hypertension, radiation therapy, bilateral TEs, acellular dermal matrix use, increasing mastectomy weight, and nipple-sparing mastectomy were associated with increased hazard of TE infection. Patients with TE infection had a 54% reconstructive failure rate within 1 year; Cox modeling showed that Black race and Gram-negative cultures were associated with increased hazard of reconstructive failure within 1 year. Patients who underwent TE replacement with an implant had the most favorable success rate following infection. CONCLUSIONS: Overall, 46% of patients admitted with a periprosthetic infection had successful salvage. Patients with TE infection should be started on intravenous antibiotics with a low threshold for operative intervention based on examination and culture data. Although IR can guide operative intervention of periprosthetic infections, our practice has shifted away from IR drainage toward definitive operative management. CLINICAL QUESTION/LEVEL OF EVIDENCE: Risk, III.
引用
- Nelson JA, Vingan PS, Graziano FD, et al. Management of the Infected Tissue Expander. Plast Reconstr Surg. 2024. PMID: 39451155. doi:10.1097/PRS.0000000000011809
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。